Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.85 |
| ▸ | GAA | P10253 | 5/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.85 |
| ▸ | MAPT | P10636 | 4/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.85 |
| ▸ | HPGD | P15428 | 4/20 | 0.85 |
| ▸ | TSHR | P16473 | 2/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.85 |
| ▸ | CDC25B | P30305 | 1/20 | 0.58 |
| ▸ | CASP6 | P55212 | 1/20 | 0.58 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.58 |
| ▸ | CFTR | P13569 | 1/20 | 0.56 |
| ▸ | HNF4A | P41235 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1809277 | 0.92 | ALDH1A1 (1.00) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL30041521 | 0.92 | ALDH1A1 (1.00) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL12846981 | 0.87 | ALDH1A1 (0.82) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL27851724 | 0.85 | ALDH1A1 (0.75) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL9129574 | 0.84 | ALDH1A1 (0.72) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL27851719 | 0.84 | ALDH1A1 (0.59) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL27642797 | 0.83 | ALDH1A1 (0.70) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL2131857 | 0.82 | ALDH1A1 (0.86) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL221403 | 0.82 | ALDH1A1 (0.81) | ALDH1A1GAAHSD17B10MAPTKDM4E | |
| SCHEMBL17262500 | 0.82 | KDM4E (0.56) | ALDH1A1GAAHSD17B10MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113173885-A | Method for synthesizing benzydamine hydrochloride impurity B | 龙曦宁（上海）医药科技有限公司 | 2021-07-27 | — | — | CN | claimed |
| CN-113173885-A | Method for synthesizing benzydamine hydrochloride impurity B | 龙曦宁（上海）医药科技有限公司 | 2021-07-27 | — | — | CN | disclosed |
| CN-1914152-B | New compounds, methods for their preparation and use thereof | ACTIVE BIOTECH AB | 2010-06-09 | — | — | CN | disclosed |
| EP-1720825-B1 | ANTHRANILIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE AS DHODH INHIBITORS | ACTIVE BIOTECH AB (SE) | 2008-07-09 | — | — | EP | disclosed |
| CN-1914152-A | New compounds, methods for their preparation and use thereof | ACTIVE BIOTECH AB (SE) | 2007-02-14 | — | — | CN | disclosed |
| EP-1720825-A1 | NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF | Active Biotech AB (SE) | 2006-11-15 | — | — | EP | disclosed |
| US-7074831-B2 | Compounds, methods for their preparation and use thereof | ACTIVE BIOTECH AB (SE) | 2006-07-11 | — | — | US | disclosed |
| US-20050187297-A1 | New compounds, methods for their preparation and use thereof | ACTIVE BIOTECH AB (SE) | 2005-08-25 | — | — | US | disclosed |
| WO-2005075410-A1 | NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF | ACTIVE BIOTECH AB (SE) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187297-A1 | New compounds, methods for their preparation and use thereof | MALT1, TPMT, FUCA1 | ALDH1A1 308/4885GAA 864/4885HSD17B10 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.